Interfor International - Weekly Security Matters Digest -September 6

Interfor International – Weekly Security & Covid Digest – September 6, 2022

Interfor’s Weekly Security & Covid Digest – September 6, 2022

Global Security Matters

  • Six people were killed in a suicide attack in Kabul on Monday.  Two Russian embassy employees were among the victims, along with Afghan citizens in the blast area.  A suicide bomber in a crowd of people was identified and shot by security forces, which triggered the explosives.  An ISIS affiliate in Afghanistan claimed responsibility for the attack.  

Covid-19 Updates

Total Deaths: 6,482,029 (1,043,446 in United States) 

US Hospitalization Rate: 9 % decline in the past week

  • The US authorized the first major makeover of the Covid-19 vaccines. The new doses target the dominant omicron subvariants as well as the original Covid-19 strain.
  • China’s government approved the world’s first inhaled vaccine against Covid-19, made by Cansino Biologics.
  • China has locked down 65 million citizens under tough Covid-19 restrictions and is discouraging domestic travel during upcoming national holidays.
  • Russia recorded more than 50,000 new daily Covid-19 cases for the first time in almost six months.
  • Japan will shorten the period of isolation for Covid-19 patients with symptoms to seven days from the current 10 days.



Global cases: 53,027                 US cases: 19,962

  • A new study is raising concerns about the effectiveness of the monkeypox vaccine used in the United States and other parts of the world. The study found that two doses of the vaccine induced relatively low levels of neutralizing antibodies against the monkeypox virus.